Skip to main content
OpenTrials

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

232 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
View all 115 locations
View Trial Details
Recruiting

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

NCT07634471

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • SCRI Oncology Partners ( Site 7000) Nashville, Tennessee, United States
  • Hadassah Medical Center ( Site 0701) Jerusalem, Israel
  • Sheba Medical Center ( Site 0702) Ramat Gan, Israel
  • Sourasky Medical Center ( Site 0704) Tel Aviv, Israel
View all 17 locations
View Trial Details
Recruiting

Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .

NCT07191249

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Rambam Health Care Campus Haifa, Israel
  • Shaare Zedek Medical Center Jerusalem, Israel
  • The Hadassah University Hospital-Ein Kerem Jerusalem, Israel
  • Tel Aviv Sourasky Medical Center (TASMC) - Ichilov Tel Aviv, Israel
View Trial Details
Recruiting

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

NCT05389293

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Georgetown University (Data Collection Only) Washington D.C., District of Columbia, United States
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities Basking Ridge, New Jersey, United States
  • Hackensack Meridian Health (Data collection only) Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

NCT06533579

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

NCT07226843

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 46 locations
View Trial Details

Related conditions